3Koch S. Bresson H. Migecet JP. et al. Experience of liver transplantation for incurable alveolar echincecosis: A ,t5 case European collahorative report. Transplantation. 2003,76:856.
4Bout D, Haque A, Capron A. Filaricidal effects of cyclosporin-A against Dipetalonema viteae in Mastomys natalensis [J]. Trans R Soc Trop Med Hyg, 1984; 78(5):670.
5Liance M, Bresson-Hadni S, Vuitton DA, et al. Effects of cyclosporin A on the course of murine alveolar echinococcosis and on specific cellular and humoral immune responses against Echinococcus multilocularis [J]. Int J Parasitol, 1992; 22(1):23.
6Adam R, Cailliez V, Majno P, et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study [J]. Lancet, 2000; 356(9230):621.
7Gillet M, Miguet JP, Mantion G, et al. Orthotopic liver transplantation in alveolar echinococcosis of the liver: analysis of a series of six patients [J]. Transplant Proc, 1988; 20(1 Suppl 1):573.
8Koch S, Bresson-Hadni S, Miguet JP, et al. Experience of liver transplantation for incurable alveolar echinococcosis: a 45-case European collaborative report [J]. Transplantation, 2003; 75(6):856.
9Suter M, Gillet M. Liver Transplantation in Alveolar Hydatid Disease [J]. Dig Surg, 1997; 14(2):229.
10Bresson-Hadni S, Franza A, Miguet JP, et al. Orthotopic liver transplantation for incurable alveolar echinococcosis of the liver: report of 17 cases [J]. Hepatology, 1991; 13(6):1061.